Correlation Between Pharvaris and BioAffinity Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharvaris and BioAffinity Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and BioAffinity Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and bioAffinity Technologies Warrant, you can compare the effects of market volatilities on Pharvaris and BioAffinity Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of BioAffinity Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and BioAffinity Technologies.

Diversification Opportunities for Pharvaris and BioAffinity Technologies

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Pharvaris and BioAffinity is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and bioAffinity Technologies Warra in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioAffinity Technologies and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with BioAffinity Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioAffinity Technologies has no effect on the direction of Pharvaris i.e., Pharvaris and BioAffinity Technologies go up and down completely randomly.

Pair Corralation between Pharvaris and BioAffinity Technologies

Given the investment horizon of 90 days Pharvaris BV is expected to under-perform the BioAffinity Technologies. But the stock apears to be less risky and, when comparing its historical volatility, Pharvaris BV is 3.65 times less risky than BioAffinity Technologies. The stock trades about -0.05 of its potential returns per unit of risk. The bioAffinity Technologies Warrant is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  78.00  in bioAffinity Technologies Warrant on August 29, 2024 and sell it today you would lose (18.00) from holding bioAffinity Technologies Warrant or give up 23.08% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Pharvaris BV  vs.  bioAffinity Technologies Warra

 Performance 
       Timeline  
Pharvaris BV 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Pharvaris BV are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Pharvaris unveiled solid returns over the last few months and may actually be approaching a breakup point.
BioAffinity Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days bioAffinity Technologies Warrant has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly fragile technical and fundamental indicators, BioAffinity Technologies may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pharvaris and BioAffinity Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharvaris and BioAffinity Technologies

The main advantage of trading using opposite Pharvaris and BioAffinity Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, BioAffinity Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies will offset losses from the drop in BioAffinity Technologies' long position.
The idea behind Pharvaris BV and bioAffinity Technologies Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges